Shattuck Labs Inc (STTK) Implied Volatility Current

Tracking STTK implied volatility helps you identify when options premiums on Shattuck Labs Inc are historically cheap or expensive, and where the best trades are hiding. Shattuck Labs Inc implied volatility reflects the market's expectation of future price movement: when STTK IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Shattuck Labs Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For STTK, tracking metrics like STTK IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on STTK signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where STTK implied volatility sits today versus where it has been. Our scanner ranks Shattuck Labs Inc implied volatility against its historical range, surfaces extremes in STTK IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Shattuck Labs Inc IV is rich or cheap — measure it, then act on it.